18F-氟二羟基苯丙氨酸PET/CT在嗜铬细胞瘤和副神经节瘤中与基因型及L型氨基酸转运系统的关系
研究纳入2007至2015年175例非转移性嗜铬细胞瘤和副神经节瘤患者,评估L-DOPA转运体表达与18F-FDOPA PET成像结果的关系。SDHx突变样本LAT3 mRNA表达较散发性显著降低(P=0.042),LAT1蛋白在93.75%的SDHx肿瘤中表达。作者认为LAT1/CD98hc下调不能解释SDHx相关肿瘤的成像表型,LAT1活性降低仍是主要假说。
要点
- 10/126(8%)患者至少一处病灶18F-FDOPA PET/CT假阴性,包括2例散发性、6例SDHD、2例SDHB。
- SDHx突变样本LAT3 mRNA表达较散发性PPGL显著降低(P=0.042)。
- LAT1蛋白在15/16(93.75%)SDHx肿瘤中表达,与18F-FDOPA阳性与否无关。
核心结论
- LAT1/CD98hc下调不能解释SDHx相关PPGL的成像表型。
- LAT1活性降低仍是主要假说,可能因细胞内氨基酸含量改变而减少18F-FDOPA摄取。
研究设计与样本
- 2007至2015年纳入175例非转移性PPGL患者,行18F-FDOPA PET/CT用于初诊分期和随访。
- 对14份和16份肿瘤样本分别进行qRT-PCR和免疫组化分析,评估CD98hc和LATs的mRNA及蛋白表达。
主要发现
- 10/126(8%)患者至少一处病灶18F-FDOPA PET/CT假阴性,其中散发性2例、SDHD 6例、SDHB 2例。
- SDHx突变样本LAT3 mRNA表达较散发性PPGL显著降低(P=0.042)。
- SDHx较散发性PPGL的CD98hc(P=0.147)和LAT4(P=0.012)呈现下降的统计学趋势。
- LAT1/LAT2 mRNA水平无差异。
- LAT1蛋白在15/16(93.75%)SDHx肿瘤中表达,与18F-FDOPA阳性与否无关;LAT1和CD98hc在6/8例18F-FDOPA阴性PPGL中共表达;1例LAT1/CD98hc缺失者18F-FDOPA摄取阳性,归因于LAT4表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: F-FDOPA is a highly sensitive and specific radiopharmaceutical for pheochromocytoma and paraganglioma (PPGL) imaging. However, 18F-FDOPA might be falsely negative in these tumors, especially those related to mutations in succinate dehydrogenase genes (SDHx). The aim of the present study was to evaluate the relationship between expression of L-DOPA transporters and 18F-FDOPA PET imaging results in PPGL. METHODS: From 2007 to 2015, 175 patients with non-metastatic PPGL were evaluated by 18F-FDOPA PET/CT for initial diagnosis/staging and follow-up. 18F-FDOPA PET/CT was considered as falsely negative for at least one lesion in 10/126 (8%) patients (two sporadic, six SDHD, two SDHB PPGLs). The mRNA and protein expression levels of CD98hc and LATs were evaluated in samples with different genetic backgrounds and imaging phenotypes. The qRT-PCR and immunohistochemical analyses were performed in 14 and 16 tumor samples, respectively. RESULTS: The SDHx mutated samples exhibited a significant decrease in mRNA expression of LAT3 when compared to sporadic PPGLs (P = 0.042). There was also a statistical trend toward decreased CD98hc (P = 0.147) and LAT4 (P = 0.012) levels in SDHx vs sporadic PPGLs. No difference was observed for LAT1/LAT2 mRNA levels. LAT1 protein was expressed in 15 out of 16 (93.75%) SDHx tumors, regardless of the 18F-FDOPA positivity. LAT1 and CD98hc were co-expressed in 6/8 18F-FDOPA-negative PPGLs. In contrast, in one case with absence of LAT1/CD98hc, 18F-FDOPA uptake was positive and attributed to LAT4 expression. CONCLUSIONS: We conclude that down-regulation of LAT1/CD98hc cannot explain the imaging phenotype of SDHx-related PPGLs. A reduced activity of LAT1 remains the primary hypothesis possibly due to a modification of intracellular amino acid content which may reduce 18F-FDOPA uptake.
引用
- Feral CC, Tissot FS, Tosello L, et al. 18F-fluorodihydroxyphenylalanine PET/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L. Eur J Nucl Med Mol Imaging. 2016. PMID: 27900521. doi:10.1007/s00259-016-3586-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。